Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET

Anders Ettrup, Mikael Palner, Nic Gillings, Martin A. Santini, Martin Hansen, Birgitte R. Kornum, Lars K. Rasmussen, Kjell Någren, Jacob Madsen, Mikael Begtrup and Gitte M. Knudsen
Journal of Nuclear Medicine November 2010, 51 (11) 1763-1770; DOI: https://doi.org/10.2967/jnumed.109.074021
Anders Ettrup
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikael Palner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nic Gillings
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin A. Santini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Birgitte R. Kornum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars K. Rasmussen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kjell Någren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Madsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikael Begtrup
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gitte M. Knudsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (11)
Journal of Nuclear Medicine
Vol. 51, Issue 11
November 1, 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET
Anders Ettrup, Mikael Palner, Nic Gillings, Martin A. Santini, Martin Hansen, Birgitte R. Kornum, Lars K. Rasmussen, Kjell Någren, Jacob Madsen, Mikael Begtrup, Gitte M. Knudsen
Journal of Nuclear Medicine Nov 2010, 51 (11) 1763-1770; DOI: 10.2967/jnumed.109.074021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET
Anders Ettrup, Mikael Palner, Nic Gillings, Martin A. Santini, Martin Hansen, Birgitte R. Kornum, Lars K. Rasmussen, Kjell Någren, Jacob Madsen, Mikael Begtrup, Gitte M. Knudsen
Journal of Nuclear Medicine Nov 2010, 51 (11) 1763-1770; DOI: 10.2967/jnumed.109.074021
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Psychedelics
  • Radiosynthesis and In Vivo Evaluation of Novel Radioligands for PET Imaging of Cerebral 5-HT7 Receptors
  • Google Scholar

More in this TOC Section

  • Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
  • [11C]ZTP-1: An Effective Short-Lived Radioligand for PET of Rat and Monkey Brain Phosphodiesterase Type 4 Subtype B
  • Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model
Show more Basic Science Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire